div>
BOTHELL, Wash., Sept. 21 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in advanced cardiac monitoring and defibrillation products, announced today that it will present at the UBS Global Life Sciences Conference at the Grand Hyatt New York Hotel on Thursday, September 28, 2006 at 8:30 a.m. Eastern Time. Mike Matysik, senior vice president and chief financial officer, will be discussing recent business accomplishments and related financial information regarding Cardiac Science.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO )
Attendance at the conference is by invitation only. Cardiac Science will offer a live audio webcast of its presentation which may be accessed at the Company’s website at www.cardiacscience.com. An archived replay of the presentation will also be available approximately three hours following the live presentation and will be available at www.cardiacscience.com until October 28, 2006.
About Cardiac Science Corporation
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor-defibrillators and cardiology data management systems. Cardiac Science also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services.
The company is the successor to various entities that have owned and operated cardiology-related businesses, which sold products under the trusted brand names Burdick(R), Powerheart(R), and Quinton(R). Cardiac Science is headquartered in Bothell, WA, and also has operations in Lake Forest, California, Deerfield, Wisconsin, Shanghai, China, Copenhagen, Denmark and Manchester, United Kingdom.
Contact: Mike Matysik, Sr. Vice President and CFO of Cardiac Science Corporation, +1-425-402-2009; or Investors, Douglas Sherk, or Jennifer Beugelmans, +1-415-896-6820, or Media, Steve DiMattia, +1-646-277-8706, all of EVC Group, Inc., for Cardiac Science Corporation.
Photo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comCardiac Science Corporation
CONTACT: Mike Matysik, Sr. Vice President and CFO of Cardiac ScienceCorporation, +1-425-402-2009; or Investors, Douglas Sherk, or JenniferBeugelmans, +1-415-896-6820, or Media, Steve DiMattia, +1-646-277-8706, allof EVC Group, Inc., for Cardiac Science Corporation
Web site: http://www.cardiacscience.com//
